XNCR Q2 2022 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$30M-55.3% YoY

Gross Profit

-$17M-56.0% margin

Operating Income

-$28M-92.8% margin

Net Income

-$34M-112.6% margin

EPS (Diluted)

$-0.67

QoQ Revenue Growth

-64.7%

Cash Flow

Operating Cash Flow

$44M

Free Cash Flow

$30M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$851M

Total Liabilities

$109M

Stockholders' Equity

$742M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$67M	-55.3%
Gross Profit	-$17M	$18M	-194.2%
Operating Income	-$28M	$9M	-408.1%
Net Income	-$34M	$52M	-165.0%

Revenue Segments

Royalties

$30M99%

Research collaboration

$200,0001%